Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BrafPanc: Binimetinib + Encorafenib in BRAF V600E Pancreatic Cancer
NCT04390243Phase 2Terminated
- Sponsor
- Academic and Community Cancer Research United
- Start
- Nov 2020
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of binimetinib, encorafenib in pancreatic cancer (PC), sponsored by Academic and Community Cancer Research United. Started Nov 2020; status: terminated.
02
Drugs
binimetinibencorafenib
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT04390243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04390243.